These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6998620)

  • 1. An in vitro assay for uni-directional migration inhibition employing 51Cr-labelled macrophages.
    Noronha-Blob L; Huang SW
    Clin Exp Immunol; 1980 Jun; 40(3):627-32. PubMed ID: 6998620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of 51Cr-labelled macrophages for the objective evaluation of macrophage migration inhibition].
    Suslov AP; Miuller U
    Biull Eksp Biol Med; 1978 Jan; 85(1):54-7. PubMed ID: 342006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of assay conditions for macrophage migration from an agarose droplet.
    Fahlbusch B; Dornberger G
    Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advantages and technical conditions of the migration inhibition test [MIF] in agarose gel (author's transl)].
    Cabarcos A; Pérez-Miranda M; Uribarrena R; Pons F
    Sangre (Barc); 1977; 22(5):541-9. PubMed ID: 333629
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 9. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

  • 10. The migration of guinea-pig macrophages in the presence of tuberculin-sensitive mouse lymphocytes and tuberculin.
    Lo ST; Han SH
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1972 Jun; 5(1):87-8. PubMed ID: 4598542
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensitization against spermatozoa antigens in the cell-linked female immunologic system detected by the migration-inhibition-factor].
    Mettler L; Scheidel P
    Fortschr Med; 1973 Sep; 91(27):1059-61. PubMed ID: 4583566
    [No Abstract]   [Full Text] [Related]  

  • 12. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed hypersensitivity pleurisy in guinea pigs; demonstration of reduced migration ability of macrophages in vitro.
    Yamamoto S; Ishikura A; Higuchi Y
    J Pathol; 1980 Jun; 131(2):137-44. PubMed ID: 7000987
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of macrophage migration by plasma factor(s) from patients with neoplasms and normal individuals.
    Bice DE; Gruwell D; Salvaggio J
    J Reticuloendothel Soc; 1976 May; 19(5):281-9. PubMed ID: 775085
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-mercaptoethanol in vitro and macrophage migration in normal and sensitized guinea pigs.
    Prokić LM; Vilić IM
    Biomed Pharmacother; 1985; 39(6):330-4. PubMed ID: 3910130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.
    Pick E
    Immunology; 1974 Mar; 26(3):649-58. PubMed ID: 4369184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of macrophage migration inhibitory factor in the HEPES-buffered agarose medium. Modification of clausen's method].
    Nakagawa J; Okimoto Y; Era K; Ito K; Fukase M
    Ryumachi; 1974 Oct; 14(3):270-3. PubMed ID: 4375308
    [No Abstract]   [Full Text] [Related]  

  • 18. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of the in vitro migration inhibition test (author's transl)].
    Sabioncello A; Dekaris D
    Lijec Vjesn; 1978 Sep; 100(9):535-42. PubMed ID: 368478
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
    Sheremata W; Cosgrove JB; Eylar EH
    N Engl J Med; 1974 Jul; 291(1):14-7. PubMed ID: 4598923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.